Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Green Cross Is Latest Korean Pharma To Struggle Under Regulatory Headwinds

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Green Cross Corp. has continued a trend among Korean pharma companies by posting relatively sluggish second quarter results
Advertisement

Related Content

In Medical Tourism Drive, Korea's JW Choongwae Links Up With Kazakhstan's JSC Chempharm To Build Manufacturing Plant
In Medical Tourism Drive, Korea's JW Choongwae Links Up With Kazakhstan's JSC Chempharm To Build Manufacturing Plant
Green Cross, LG Life Sciences Team Up To Sell Osteoarthritis Drug To Compete With Pfizer's Celebrex
Green Cross, LG Life Sciences Team Up To Sell Osteoarthritis Drug To Compete With Pfizer's Celebrex
Korea's Celltrion Sees Growth Trend Continue On Strength Of Biosimilar Validation Batch Orders
Korea's Tightened Regulatory Grip Drops Daewoong and Dong-A Rx Sales In Q2, But OTC Sales Strong
Korea's Tightened Regulatory Grip Drops Daewoong and Dong-A Rx Sales In Q2, But OTC Sales Strong
Korea's Green Cross Strengthens Vaccine Supply Chain For Growing Export Demand
Green Cross Says It Secured Korea's Largest-ever Agreement For Finished Product Export
Advertisement
UsernamePublicRestriction

Register

SC078721

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel